The Net Margin of Lionco Pharmaceutical Group Co Ltd (603669.SS) is -59.85%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | -59.85% |
| 2024-12-31 | -34.49% |
| 2023-12-31 | -76.97% |
| 2022-12-31 | -67.71% |
| 2021-12-31 | 8.90% |
| 2020-12-31 | 15.99% |
| 2019-12-31 | 12.33% |
| 2018-12-31 | 10.94% |
| 2017-12-31 | 16.02% |
| 2016-12-31 | 32.16% |